The Cystic Fibrosis Foundation in Bethesda, Maryland, has announced grants totaling $23 million to eleven cystic fibrosis research and treatment centers across the country.
Awarded through CFF's Research Development Program, the grants include $2.1 million to the Colorado Research Development Program in Denver in support of research projects focused on diagnosing and treating Nontuberculous Mycobacteria (NTM) infections in cystic fibrosis. Among other things, the fund will support the development of a National Reference Lab capable of improving analysis of NTM samples as well as better detection of potential outbreaks within and between centers.
In addition, the Children’s Healthcare of Atlanta, Emory University, and Georgia Tech will receive $1.8 million over the next four years to establish a CF research development program. At CF@LANTA RDP, scientists will focus on the underlying processes that cause permanent lung damage when pulmonary exacerbations occur as well as the advancement of CF-related diabetes, the most frequent co-existing condition linked with cystic fibrosis. The foundation also renewed four-year grants to nine other programs in the RDP network that share resources such as core facilities and support staff.
"We have been working to build infrastructure funding for the CF program for many years," said Nael McCarty, Marcus Professor of Cystic Fibrosis at Emory University School of Medicine. "This is a very important success for Atlanta's CF research and clinical community."